I'm LongbridgeAI, I can summarize articles.Hong Kong's niche stocks are splitting along policy-driven fault lines. Yunji Technology (2915.HK) rocketed 1,539% in one week following industrial policy updates, while SEER TECH (6106.HK) and MicroPort MedBot-B (2252.HK) faced divergent fates—the latter suspended trading despite posting its first half-year profit amid a rental payment probe.
In biotech, Fujian Haixi Pharmaceuticals (2637.HK) drew bullish analyst revisions after positive nAMD trial data, with target prices averaging 54% upside. Consumer plays painted a mixed picture: Damai Entertainment (1060.HK) and NAYUKI (2150.HK) lagged benchmarks on slowing IP monetization, while QIYUNSHAN FOOD (2797.HK) surged 29% over two weeks without clear catalysts.
Semiconductor and materials stocks showed contrasting trajectories. NOVOSENSE (2676.HK) turned profitable on AI-driven demand, and WEIMOB INC (2013.HK) stabilized losses with new AI tools. Woer Heat-Shrinkable Material (9981.HK), despite winning a CNH 7 million contract, hit all-time lows. Global investors are shifting focus from valuation metrics to tangible operational milestones, with policy responsiveness emerging as the critical differentiator.
